波士顿科学宣布全球重组并将裁员，预计产生7亿至8亿美元税前费用

Boston Scientific Restructuring To Trim Workforce
Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Cryptocurrency
Crypto
Blockchain
Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
World
White House
Elections
General News
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Music news
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium Services
Premium
Intelligent Investor
Biotech Investor
NEW
Login
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Corp. News
Market News
Health News
Entertainment News
Music News
Biotech Daily Dose
By
TajSabreen Ahamed
✉
|
Published:
7/28/2026 3:31 AM ET
Follow Us
Join Us
Add
as your preferred news source on Google
Add Now
Boston Scientific Corp (
BSX
) has unveiled a sweeping global restructuring program, according to its Form 8-K filing with the U.S. Securities and Exchange Commission. The plan, approved by the board of directors, is designed to streamline operations, optimize supply chains, and align resources with the company's strategic priorities.
The restructuring, set to begin this year and continue through 2029, will involve transferring certain production lines among facilities, functional transformation and organizational changes aimed at driving sustained cost efficiencies. While Boston Scientific noted that new roles will be created in growth areas, the company confirmed that headcount reductions are expected as part of the initiative.
The filing estimates total pre-tax charges of $700 million to $800 million, with $600 million to $700 million in future cash outlays. Termination benefits alone are projected at $275 million to $300 million, alongside $300 million to $350 million in transfer costs and $125 million to $150 million in other expenses such as consulting fees and contractual cancellations. Once complete, the program is expected to reduce gross annual pre-tax expenses by approximately $500 million, with a substantial portion of savings reinvested into strategic growth initiatives.
Boston Scientific emphasized that detailed plans for employee impacts will be developed region by region, in consultation with representative bodies where required under local laws.
BSX has traded between $42.20 and $109.50 over the past year. The stock closed Monday's trading at $45.51, up 2.85%. During overnight trading session the stock is at $45.75, up 0.53%.
For comments and feedback contact: editorial@rttnews.com
Business News
Biotech Stocks Facing FDA Decision In July 2026
Biotech Stocks Facing FDA Decision In June 2026
Biotech Stocks Facing FDA Decision In May 2026
Latest Updates on Middle East War
U.S. Dollar Ticks Higher As Easing Middle East Tensions Lowers Fed Rate Hike Expectations
July 27, 2026 17:00 ET
Canadian Stocks Edge Higher Amid Easing Middle East Tensions
July 27, 2026 16:26 ET
Crude Oil Nosedives As Middle East Tension Eases After U.S. And Iran Pause Mutual Attacks
July 27, 2026 14:36 ET
Gold Inches Higher As Middle East Tensions Ease, Crude Oil Plunges Sharply
July 27, 2026 13:40 ET
U.S. Dollar Ticks Higher As U.S. Steps Up Threats On Iran While Crude Oil Prices Plunge
July 24, 2026 17:00 ET
View More
Global Economics Weekly Update - July 20 – July 24, 2026
July 25, 2026 02:46 ET
The latest policy decision from the European Central Bank dominated the scene this week that was relatively slow for economics news flow. In the U.S., main highlights were the weekly initial jobless claims and new home sales data. In Europe, the ECB rate decision and the latest inflation figures from the U.K. drew attention. In Asia, results of a private sector survey from India were in focus.
View More Videos
RELATED NEWS
Boston Scientific: FRACTURE Trial Meets Pre-specified Safety, Effectiveness Endpoints
Boston Scientific Agrees To $2 Bln ASR
Boston Scientific Invests $1.5 Bln In Exchange Of 34% Stake In MiRus
Latest Updates on COVID-19
KFF Poll Finds AI Health Chatbot Users More Likely To Believe Vaccine Myths
July 01, 2026 14:27 ET
Editor's Pick
Most Read
Most Emailed
AstraZeneca Q2 Pre-tax Profit Down, But EPS Rise; Backs Positive FY26 View
July 27, 2026 04:19 ET
Verizon Lifts FY26 View Despite Weak Q2, Expands Buyback To Up To $4.5 Bln; Shares Up
July 24, 2026 10:21 ET
EU Commission Flags TikTok's Minor Account Safety Gaps
July 24, 2026 09:56 ET
Volkswagen Cuts FY26 Revenue View After Weak Q2 Profit, Volume
July 24, 2026 05:33 ET
T-Mobile US Q2 Profit Edges Up, Net Additions Drop, Backs FY26 View; Stock Down
July 23, 2026 09:43 ET
WSP Raises Arcadis Acquisition Offer To €51.50 After Initial Rejection
July 24, 2026 11:50 ET
Amapá Minerals Reveals Pricing Of IPO Of 127.27 Mln Common Shares At $1.10/Shr
July 24, 2026 01:42 ET
Union Pacific Signs MoU With CN Supporting Proposed Norfolk Southern Merger
July 23, 2026 01:19 ET
Eligible Amazon Prime Members Have Until July 27 To Claim Up To $51 In FTC Settlement
July 24, 2026 17:15 ET
ATOSS H1 Profit Rises On Higher Revenue; Maintains FY26, FY27 Forecast
July 24, 2026 02:41 ET
Safety Insurance To Be Acquired By Mapfre In $1.54 Bln All-Cash Deal
July 23, 2026 17:11 ET
Nestlé SA H1 Profit Declines, Confirms FY26 Outlook
July 23, 2026 02:21 ET
Carpenter Technology CEO Brian Malloy Passes Away; Tony Thene Named CEO
July 27, 2026 08:18 ET
Argenx To Buy Forte Biosciences In Around $2.2 Bln Cash Deal; Forte Biosciences Shares Climb
July 27, 2026 01:24 ET
West Bancorporation Inc. Reveals Rise In Q2 Profit
July 23, 2026 09:02 ET
Westports Holdings Berhad Bottom Line Advances In Q2
July 23, 2026 00:56 ET
NVR Inc. Bottom Line Declines In Q2
July 23, 2026 09:05 ET
SFS Group AG H1 Income Rises
July 23, 2026 00:58 ET
ACNB Corporation Reports Increase In Q2 Bottom Line
July 23, 2026 09:07 ET
Cembra Money Bank AG Announces Increase In H1 Income
July 23, 2026 01:02 ET
Mapletree Industrial Trust Profit Drops In Q1
July 23, 2026 09:11 ET
Givaudan H1 Profit, Sales Down; Backs LFL Sales Growth View Ahead
July 23, 2026 01:03 ET
Kearny Financial Corp. Q4 Sales Increase
July 23, 2026 09:16 ET
Pihlajalinna Oyj Bottom Line Falls In Q2
July 23, 2026 01:07 ET
Mapletree Industrial Trust Q1 Profit Drops
July 23, 2026 09:23 ET
LS ELECTRIC Q2 Operating Income Rises
July 23, 2026 01:17 ET
Editors Pick
Loading...
Copyright © 2026 RTTNews. All rights reserved.
By using this site, you agree to the
Terms of Service
.
About Us
Privacy
Sitemap